Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CANMAT Depression Guidelines (2016) > Section III. Pharmacological Treatment > Flashcards

Section III. Pharmacological Treatment Flashcards

1
Q

List first line antidepressants [15]:

A
  1. Agomelatine
  2. Bupropion
  3. Citalopram
  4. Desvenlafaxine
  5. Duloxetine
  6. Escitalopram
  7. Fluoxetine
  8. Fluvoxamine
  9. Mianserin
  10. Milnacipran
  11. Mirtazepine
  12. Paroxetine
  13. Sertraline
  14. Venlafaxine
  15. Vortioxetine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List 2nd line antidepressants [7]:

A
  1. Amitriptyline
  2. Levomilnacipran
  3. Moclobemide
  4. Quetiapine
  5. Selegiline transdermal
  6. Trazodone
  7. Vilazodone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 3rd line antidepressants [3]:

A
  1. Phenlezine
  2. Tranylcypromine
  3. Reboxetine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Poor response to medication linked to [3]:

A
  1. increasing age
  2. Presence of anxiety
  3. Long episode duration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the suggested treatment for MDD with anxious distress?

A

Antidepressant with efficacy in GAD (no difference between SSRIs, SNRIs, and Bupropion - Level 2 evidence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the suggested treatment for MDD with catatonic features?

A

Benzos (Level 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the suggested treatment for MDD with melancholic features?

A

No specific antidepressants show superiority (Level 2)

Studies done with TCAs & SNRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the suggested treatment for MDD with atypical features?

A

No specific antidepressants show superiority (Level 2)

Older studies show MAOIs superior to TCAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the suggested treatment for MDD with psychotic features?

A

Use antipsychotic + antidepressant co-treatment (Level 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the suggested treatment for MDD with mixed features?

A

Lurasidone (Level 2)
Ziprasidone (Level 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the suggested treatment for MDD with seasonal patter?

A

No antidepressants have shown superiority (Level 2 & 3)

Can consider SSRIs, agomelatine, Bupropion, moclobemide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the suggested treatment for MDD with cognitive dysfunction?

A

Vortioxetine (Level 1)
Bupropion (Level 2)
Duloxetine (Level 2)
SSRIs (Level 2)
Moclobemide (Level 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the suggested treatment for MDD with sleep disturbances?

A

Agomelatine (Level 1)
Mirtazapine (Level 2)
Quetiapine (Level 2)
Trazodone (Level 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the suggested treatment for MDD with somatic symptoms?

A

Duloxetine for pain (Level 1)
Duloxetine for energy (Level 2)
Other SNRIs for pain (Level 2)
Bupropion for fatigue (Level 1)
SSRIs for fatigue (Level 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which medication results in improved processing speed, executive control, and cognitive control?

A

Vortioxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which antidepressants show superior response in treating MDD?

A

Escitalopram (Level 1)
Mirtazepine (Level 1)
Sertraline (Level 1)
Venlafaxine (Level 1)
Agomelatine (Level 2)
Citalopram (Level 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which antidepressants show (low quality) evidence of lower risk for sexual side effects [5]?

A

Agomelatine
Bupropion
Mirtazepine
Vilazodone
Vortioxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

which medication might have increased risk of suicide [ Black Box morning]?

A

Paroxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what % of adults had reduced risk of suicide went on SSRI?

A

reduced by:
- 40% in adults
- 50% among elderly people

20
Q

Exposure to SSRI almost _______ the risk of suicide and suicide attempts among teenagers

Why?

A

Doubles

Possibly because only the most severely ill teens are prescribed antidepressants to begin with

21
Q

Which antidepressants require monitoring for prolonged QTC?

A
  1. Citalopram
  2. Escitalopram
  3. Quetiapine
22
Q

but our normal ranges for QTC?

A

normal QT interval is:
- less than 450 ms in men
- less than 460 ms in women

23
Q

what type of medication which increased risk of falls and fractures?

A

SSRI

24
Q

which time frame is a person at increased risk for falls and fractures with an SSRI?

A

Highest risk is in the first six weeks of SSRI exposure

25
Q

what antidepressant is hyponatraemia often associated with, particularly in elderly patients?

A

SSRI

26
Q

How do SSRIs affect bleeding and clotting?

A

SSRIs inhibit platelet aggregation by altering platelet serotonin receptors

Therefore, modest increase in risk of GI bleeding

27
Q

What common OTC medication increases risk of G.I. bleeding when also on SSRIs?

A

NSAIDs

28
Q

Should you regularly monitor LFTs when on antidepressant medication?

For which medication in particular should you consider monitoring LFTs?

A

No, elevation of liver enzymes is uncommon

However, agomelatine can potentially elevate liver enzymes and in some cases, lead to toxic hepatitis

29
Q

True or false, CANMAT recommends routine use of pharmacogenetics testing

A

False.

30
Q

How do you define “early improvement” when starting an antidepressant?

A

> 20-30% reduction in symptoms from baseline in a depression rating scale after 2 to 4 weeks

31
Q

how soon might a patient show positive response and even remission with early improvement after starting an antidepressant?

A

6 to 12 weeks

32
Q

when should you increase the antidepressant dose for “non-improvers”?

A

2 to 4 weeks if medication is tolerated

33
Q

what are the two faces of depression treatment and their definitions?

A
  1. Acute treatment [getting to symptomatic remission]
  2. Maintenance phase [preventing relapse and recurrence]
34
Q

What duration of time do the guidelines recommend to continue treatment?

A

And he treated with anti-depressants for 6 to 9 months after teething symptomatic remission

However, those with risk factors for recurrence should have antidepressant treatment extended to 2 years or more

35
Q

What are the symptoms of discontinuation syndrome/symptoms?

A

FINISH

Flu-like sxs
Insomnia
Nausea
Imbalance
Sensory disturbances
Hyperarousal

36
Q

What factors should you consider to maintain treatment with antidepressants for longer than two years? [6]

A
  1. Frequent, recurrent episodes
  2. Severe episodes [psychosis, severe impairment, suicidality]
  3. Chronic episodes
  4. Presence of comorbid psychiatric or other medical conditions
  5. Presence of residual symptoms
  6. Difficult-to-treat episodes
37
Q

which medication’s are most likely to be associated with discontinuation effects? [2

A
  1. Immediate release paroxetine
  2. Immediate release Venlafaxine
38
Q

Which medication’s are least likely to result in discontinuation syndrome and why? [2]

A
  1. Fluoxetine
  2. Vortioxetine

Due to long half-life

39
Q

what is considered partial response to anti-depressants?

A

Partial response is 25 to 49% reduction in symptoms scores

40
Q

what is considered no response to antidepressants?

A

Less than 25% reduction in symptoms scores is considered a no response outcome

41
Q

List the first line adjunctive medications for treatment of depression [3]

A

Aripiprazole
Quetiapine
Risperidone

** all level 1 evidence

42
Q

List the second line recommended medication’s for adjunct treatment of depression [7]

A
  1. Brexpiprazole (level 1)
  2. Bupropion (level 2)
  3. Lithium (level 2)
  4. Mirtazepine (level 2)
  5. Modafinil (level 2)
  6. Olanzapine (level 1)
  7. Triiodothyronine (level 2)
43
Q

List the third line recommended objective agents for treatment of depression [4]

A
  1. Other antidepressants (level 3)
  2. Other stimulants (methylphendiate, lisdexamphetamine, etc.) (level 3)
  3. TCAs (level 2)
  4. Ziprasidone (level 3)
44
Q

In the CANMAT guidelines, what level 1 evidence medication is suggested as an adjunct for non-response depression treatment?

A

Ketamine

45
Q

True or false – adjunctive aripiprazole was inferior to antidepressant switch on efficacy outcomes, including response and remission

A

False - adjunct of aripiprazole was superior to anti-depressants which

46
Q

What 5 steps should you take when considering switching to another antidepressant?

A
  1. It is the first antidepressant trial
  2. There are poorly tolerated side effects to the initial antidepressant
  3. There is no response [<25% improvement] to the initial antidepressant
  4. There is more time to wait for a response [less severe, less functional impairment]
  5. Patient prefers to switch to another antidepressant
47
Q

What are the factors to consider when considering adding an adjunctive medication for treatment of depression [6]?

A
  1. There have been 2+ antidepressant trials
  2. The initial antidepressant is well tolerated
  3. There is partial improvement [> 25% improvement] to the initial antidepressant
  4. There are specific residual symptoms or side effects to the initial antidepressant that can be targeted
  5. There is less time to wait for a response [more severe, more functional impairment]
  6. Patient prefers to add on another medication

CANMAT Depression Guidelines (2016) (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions